FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

34155811000001108: Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1783141000001110 Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1783151000001113 Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has dispensed dose form Conventional release dispersion for infusion true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route dispersioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has dispensed dose form Dispersion for infusion false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has specific active ingredient Irinotecan sucrosofate salt pegylated liposomal true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Irinotecan true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Is a Product containing irinotecan false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has active ingredient Irinotecan true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has dispensed dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has specific active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has specific active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Is a Irinotecan pegylated liposomal true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has specific active ingredient Irinotecan hydrochloride trihydrate liposomal pegylated false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) Is a True Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials 1 vial Has VMP True Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start